Patent Application
Provisional
App. No. 60/936,720
· Confirmation No. 5117
3-Hydroxyisothiazole-4-carboxamidine derivatives as Chk2 inhibitors
Provisional Application Expired
Inventors
Jim Wu
Aliso Viejo, CA
Huanming Chen
Irvine, CA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 69758
- Docket No.
- P21262
- Confirmation No.
- 5117
Child
Claims priority from a provisional application
→
App. 12/143,672
· US 8,067,452
Filed 2008-06-20
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Child
PCT
Claims priority from a provisional application
→
PCT/US2008/067763
Filed 2008-06-20
· RO PROCESSING COMPLETED-PLACED IN STORAGE
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS NORTH AMERICA,
CORIA LABORATORIES, LTD.,
DOW PHARMACEUTICAL SCIENCES, INC.,
ATON PHARMA, INC.
PATENT SECURITY RELEASE AGREEMENT
Recorded 2011-03-14
from
ATON PHARMA, INC.,
CORIA LABORATORIES, LTD.,
DOW PHARMACEUTICAL SCIENCES, INC.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS NORTH AMERICA
SECURITY AGREEMENT
Recorded 2010-10-04
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 60/936,720
- Filed
- 2007-06-21
External Links